DAPAZORG 5 MG COM REV CT BL AL/AL X 100

Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil

  • Registration number 1650700500057
  • GGREM 569926080018607
  • Barcode 7908101202541

What the source publishes

Holder
CAMBER FARMACEUTICA LTDA
Active ingredients
DAPAGLIFLOZINA
Package
5 MG COM REV CT BL AL/AL X 100
Supply regime
Tarja Vermelha
Product type
Similar
Therapeutic class
A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
Prescription
Prescription or restricted

Names this record is found by

Complete source data
br:cmed:presentations:569926080018607
{
  "name": "DAPAZORG 5 MG COM REV CT BL AL/AL X 100",
  "holder": "CAMBER FARMACEUTICA LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7908101202541"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "569926080018607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "24.633.934/0001-29",
  "priceRegime": "Regulado",
  "productName": "DAPAZORG",
  "productType": "Similar",
  "hospitalOnly": false,
  "presentation": "5 MG COM REV CT BL AL/AL X 100",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "153.97",
    "icms-12": "174.97",
    "icms-17": "185.51",
    "icms-18": "187.77",
    "icms-19": "190.09",
    "icms-20": "192.46",
    "icms-21": "194.90",
    "icms-22": "197.40",
    "icms-23": "199.96",
    "icms-17.5": "186.63",
    "icms-19.5": "191.27",
    "icms-20.5": "193.67",
    "icms-22.5": "198.67",
    "icms-12-alc": "172.87",
    "icms-17-alc": "183.28",
    "icms-18-alc": "185.52",
    "icms-19-alc": "187.81",
    "icms-20-alc": "190.15",
    "icms-21-alc": "192.56",
    "icms-22-alc": "195.03",
    "icms-23-alc": "197.56",
    "withoutTaxes": "152.12",
    "icms-17.5-alc": "184.39",
    "icms-19.5-alc": "188.97",
    "icms-20.5-alc": "191.35",
    "icms-22.5-alc": "196.29"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "DAPAGLIFLOZINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "212.23",
    "icms-12": "241.18",
    "icms-17": "255.71",
    "icms-18": "258.82",
    "icms-19": "262.02",
    "icms-20": "265.29",
    "icms-21": "268.65",
    "icms-22": "272.10",
    "icms-23": "275.62",
    "icms-17.5": "257.25",
    "icms-19.5": "263.65",
    "icms-20.5": "266.95",
    "icms-22.5": "273.85",
    "icms-12-alc": "238.98",
    "icms-17-alc": "253.37",
    "icms-18-alc": "256.47",
    "icms-19-alc": "259.64",
    "icms-20-alc": "262.87",
    "icms-21-alc": "266.20",
    "icms-22-alc": "269.62",
    "icms-23-alc": "273.12",
    "withoutTaxes": "210.30",
    "icms-17.5-alc": "254.91",
    "icms-19.5-alc": "261.24",
    "icms-20.5-alc": "264.53",
    "icms-22.5-alc": "271.36"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "DAPAGLIFLOZINA"
  ],
  "therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1650700500057",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "A10P1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:569926080018607"